Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DUPILUMAB vs DURVALUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DUPILUMAB vs DURVALUMAB: Safety Overview

Metric DUPILUMAB DURVALUMAB
Total FAERS Reports 379,249 17,142
Deaths Reported 1,536 5,088
Death Rate 0.4% 29.7%
Hospitalizations 17,008 5,968
Average Patient Age 44.7 yrs 65.7 yrs
% Female Patients 61.2% 35.1%
Manufacturer sanofi-aventis U.S. LLC AstraZeneca Pharmaceuticals LP
Route SUBCUTANEOUS INTRAVENOUS
Marketing Status Prescription Prescription